Role of CD36, the Macrophage Class B Scavenger Receptor, in Atherosclerosis

Abstract: Recent work in the field of atherosclerosis has greatly expanded our knowledge of the pathogenesis of this disease. Scavenger receptors, including CD36, are thought to be most important early in the disease progression during macrophage uptake of modified LDL and foam cell formation. Genetically engineered murine models have been used to elucidate the contribution of the different scavenger receptors, to identify specific ligands related to LDL modifications, and to assess the possible therapeutic ramifications of targeting scavenger receptors. We have demonstrated a major role for CD36 in macrophage foam cell development and subsequent lesion development in vivo. Absence of CD36 in an atherogenic Apo E null background resulted in a 70% decrease in total lesion area in Western diet‐fed mice. We have also made significant progress in our understanding of the regulation of expression of CD36 and have demonstrated that OxLDL can stimulate its own uptake by induction of CD36 gene expression. The mechanism by which OxLDL upregulates CD36 involves activation of the transcription factor, PPAR‐γ.

[1]  S. Hazen,et al.  Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. , 2000, The Journal of clinical investigation.

[2]  R. Silverstein,et al.  A Null Mutation in Murine CD36 Reveals an Important Role in Fatty Acid and Lipoprotein Metabolism* , 1999, The Journal of Biological Chemistry.

[3]  K. Matsumoto,et al.  CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[4]  Seth M. Klein,et al.  Comparison of Class B Scavenger Receptors, CD36 and Scavenger Receptor BI (SR-BI), Shows That Both Receptors Mediate High Density Lipoprotein-Cholesteryl Ester Selective Uptake but SR-BI Exhibits a Unique Enhancement of Cholesteryl Ester Uptake* , 1999, The Journal of Biological Chemistry.

[5]  K. Matsumoto,et al.  Oxidized LDL increases and interferon-gamma decreases expression of CD36 in human monocyte-derived macrophages. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[6]  R. Evans,et al.  PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL , 1998, Cell.

[7]  R. Evans,et al.  Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ , 1998, Cell.

[8]  Jihong Han,et al.  Native and Modified Low Density Lipoproteins Increase the Functional Expression of the Macrophage Class B Scavenger Receptor, CD36* , 1997, The Journal of Biological Chemistry.

[9]  R. Silverstein,et al.  Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[10]  L. Yesner,et al.  Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. , 1996, Blood.

[11]  Helen H. Hobbs,et al.  Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor , 1996, Science.

[12]  D. Steinberg,et al.  The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[13]  B. Spiegelman,et al.  Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma. , 1995, Current opinion in genetics & development.

[14]  S. Yamashita,et al.  Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. , 1995, The Journal of clinical investigation.

[15]  A. Rigotti,et al.  The Class B Scavenger Receptors SR-BI and CD36 Are Receptors for Anionic Phospholipids (*) , 1995, The Journal of Biological Chemistry.

[16]  R. Silverstein,et al.  CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis , 1995, The Journal of experimental medicine.

[17]  Y. Matsuzawa,et al.  Identification of molecular defects in a subject with type I CD36 deficiency. , 1994, Blood.

[18]  D. Steinberg,et al.  Recognition of oxidatively damaged erythrocytes by a macrophage receptor with specificity for oxidized low density lipoprotein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  H. Ikeda,et al.  Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. , 1992, Blood.

[20]  M. Freeman,et al.  Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Narumiya,et al.  Multiple receptors for modified low density lipoproteins in mouse peritoneal macrophages: different uptake mechanisms for acetylated and oxidized low density lipoproteins. , 1989, Biochemical and biophysical research communications.

[22]  J L Witztum,et al.  Low density lipoprotein undergoes oxidative modification in vivo. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. Edwards,et al.  Macrophage lipoprotein receptors , 1988, Journal of Cell Science.

[24]  D. Steinberg,et al.  Lipoproteins and the pathogenesis of atherosclerosis. , 1987, Circulation.

[25]  M. Sporn,et al.  Some recent advances in the chemistry and biology of transforming growth factor-beta , 1987, The Journal of cell biology.

[26]  J. Barnwell,et al.  Isolation of the thrombospondin membrane receptor. , 1987, The Journal of clinical investigation.

[27]  D. Steinberg,et al.  Recognition of solubilized apoproteins from delipidated, oxidized low density lipoprotein (LDL) by the acetyl-LDL receptor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.